NCT02519608View on ClinicalTrials.gov

ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

January 31, 2017

Conditions
Coronary Artery DiseaseChronic Obstructive Pulmonary Disease
Interventions
DRUG

Aspirin 100 mg

Patients with COPD and SCAD undergoing PCI and stent implantation will receive aspirin

DRUG

Ticagrelor

Patients with COPD and SCAD undergoing PCI and stent implantation will receive according randomization aspirin + ticagrelor (loading dose 180 mg + maintenance 90 mg x2)

DRUG

Clopidogrel

Patients with COPD and SCAD undergoing PCI and stent implantation will receive according randomization aspirin + clopidogrel (loading dose 600 mg + maintenance 75 mg)

Trial Locations (1)

44124

University Hospital of Ferrara, Cona

All Listed Sponsors
lead

University Hospital of Ferrara

OTHER

NCT02519608 - ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts | Biotech Hunter | Biotech Hunter